2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions

View by Date

Thursday, June 23, 2016

12:00pm-1:30pm: Predicting risk of sarcopenia in people with Parkinson’s disease

A.P.C. Loureiro, B. Yamaguchi, I.L.P. Villegas, M.P. Ferreira, V.L. Israel (Curitiba, Brazil)

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Predicting therapeutic effects of atomoxetine and citalopram on response inhibition in Parkinson’s disease

J.B. Rowe, C. Rae, C. Nombela, T. Ham, P. Vazquez, I. Coyle-Gilchrist, C.R. Housden, B.J. Sahakian, T.W. Robbins, Z. Yes (Cambridge, United Kingdom)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Predictive validity of statistical models of Parkinson’s disease progression

A. Mendes, A. Gonçalves, N. Vila-Chã, M. Calejo, I. Moreira, J. Fernandes, J. Damásio, A. Bastos-Lima, S. Cavaco (Porto, Portugal)

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia

J. Jankovic, S. Marc, A. Aubrey (Houston, TX, USA)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism

G. Calandra-Buonaura, L. Sambati, I. Gessaroli, A. Turrini, R. Terlizzi, G. Giannini, P. Guaraldi, P. Cortelli (Bologna, Italy)

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Priapism and hypersexuality associated with rotigotine in an elderly Parkinsonian patient: A case report

A. Cannas, M. Meloni, M.M. Mascia, P. Solla, G. Orofino, R. Farris, D. Ciaccio, E. Binaghi, F. Marrosu (Nuoro, Italy)

Neuropharmacology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Probable REM sleep behaviour disorder and detrusor overactivity in primary cervical dystonia- A case report

S.L. Bhadran, M.G.J. Jacob, S. Kripal (Thrissur, India)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Profile of urgent care visits in movement disorders

J.T. Lazarus, V.D. Sharma, L. Scorr, S. Factor (Atlanta, GA, USA)

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Progress in the development of small molecules based on the coumarin core as multifunctional neuroprotective agents

M.J. Matos, D. Viña, F. Rodríguez-Enríquez, S. Vilar, L. Santana, E. Uriarte (Santiago de Compostela, Spain)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Progressive encephalomyelitis with rigidity and myoclonus (PERM) in an intellectually disabled patient initially misdiagnosed as neuroleptic malignant syndrome (NMS)

Z. Xu, K. Prasad, T. Yeo (Singapore, Singapore)

Other · Exhibit Hall located in Hall B, Level 2